Targeted integration of adeno‐associated virus (AAV) into human chromosome 19.R. Jude Samulski, Lynne A. Hunter, J. David Brook et al.|The EMBO Journal|1991Cited by 774
Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.Lameh Fananapazir, Dorothea McAreavey, Dominique Tripodi et al.|Circulation|1994Cited by 383
Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.Giovanni Cuda, Nava Epstein, James R. Sellers et al.|Journal of Clinical Investigation|1993Cited by 242
Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.Nava Epstein, Lameh Fananapazir, F Cyran et al.|Circulation|1992Cited by 230
Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.Lameh Fananapazir, Nava Epstein|Circulation|1994Cited by 226